Insmed Incorporated (INSM) — Fair Value Analysis

Base-case fair value (P50): $108.27 · Current price: $115.61 · Verdict: Fairly Valued

The Verdict on INSM

Based on our Monte Carlo simulations, Insmed Inc (INSM) is currently assessed as Fairly Valued. While INSM’s current price of $115.61 is slightly above our median fair value (P50) of $108.27, resulting in an -6.3% gap, this marginal difference places the stock squarely in our "Fairly Valued" category. This robust analysis, spanning thousands of forward scenarios, indicates that the market price closely reflects INSM's intrinsic worth under typical conditions, despite the minor premium implied by the $115.61 relative to the $108.27. For investors asking if INSM is overvalued, our models suggest it is hovering near fair value, rather than being significantly stretched.

How INSM stacks up against peers

Insmed's operational and financial health is currently rated as an average quality tier compared to its sector peers. This average rating is a key input into our Monte Carlo simulations, influencing the range and probability distributions of potential future outcomes that culminate in our $108.27 fair value. An average quality tier suggests that while INSM exhibits a stable profile, it doesn't present the compelling financial strength or operational efficiencies that would typically warrant a significant premium or a robust margin of safety in our fair value models. The -6.3% figure, reflecting the gap between $115.61 and $108.27, is thus grounded in an assessment of the company's relative competitive standing.

What this means for investors

Investors should consider the Fairly Valued verdict in light of the -6.3% gap between INSM's $115.61 and our $108.27 estimate. The Monte Carlo simulations imply a balanced risk-reward profile, with the current valuation closely aligning with the company's inherent value. While the $115.61 slightly exceeds the $108.27, this small premium does not, at this juncture, suggest a significant overvaluation requiring immediate defensive action. Understanding the broader distribution of potential outcomes – including more optimistic bull case scenarios and more challenging downside scenarios – is crucial for informed decision-making. Sign up for a free FairCurve account to see the full bear and bull distribution for INSM and track its fair value as new fundamentals are released.